The Label That Sold Itself
Walk into any supermarket and you'll find a divide at the soap aisle: plain soap on one side, antibacterial soap on the other, the latter typically 20–50% more expensive and stamped with claims about killing 99.9% of germs. By 2014, roughly 40% of all liquid hand soaps sold in the United States contained triclosan, the most common antibacterial agent in consumer products. The logic seemed obvious. Soap that kills bacteria must be better than soap that doesn't.
Allison Aiello didn't assume. A University of Michigan epidemiologist, she assembled every published study comparing triclosan-containing soaps with plain soaps in real-world community settings: homes, schools, and daycare centers where people actually wash their hands, not hospital operating rooms or laboratory petri dishes. Twenty-seven studies. Published between 1980 and 2006.
The result was unambiguous. Soaps containing triclosan at concentrations between 0.1% and 0.45%, the entire range sold to consumers, were no more effective than plain soap at preventing infectious illness symptoms or reducing bacterial levels on hands (Aiello et al., 2007).
Twenty Seconds Is Not Enough Time
Triclosan does kill bacteria. But it needs prolonged exposure, and that distinction matters enormously when the average handwash lasts twenty seconds. Min-Suk Rhee and colleagues at Korea University tested this directly by exposing 20 bacterial strains to antibacterial and plain soap under conditions mimicking real handwashing: 20 seconds at room temperature and at 40°C (Kim et al., 2015).
The results showed no significant difference between the two soaps, not at either temperature and not across any of the 20 bacterial strains tested.
Then they extended contact to nine hours. Only then did the antibacterial soap show a statistically significant advantage over plain soap, a result that might impress a microbiologist studying bacterial cultures overnight but means nothing for someone standing at a bathroom sink. That is roughly 1,600 times longer than anyone washes their hands.
Triclosan needs nine hours to beat plain soap.
"Honestly, we expected the results to a certain degree," Rhee told Chemistry World. "Commercial antibacterial soaps on the market generally contain less than 0.3% triclosan and washing hands takes only a few seconds."
Thirty Studies Confirm It
In 2008, Aiello expanded her work into a formal meta-analysis of 30 hand-hygiene trials in community settings, and the pooled data told the same story: handwashing with plain soap reduced gastrointestinal illness by 31% (95% CI: 19%–42%) and respiratory illness by 21% (95% CI: 5%–34%), while adding antibacterial ingredients produced no additional reduction whatsoever (Aiello et al., 2008). What worked best? Not the chemistry, but the technique: handwashing education with ordinary soap proved most effective of all.
A separate focused review in Pharmacotherapy corroborated the picture: when triclosan was introduced in community settings, "no beneficial effects were observed on the reduction of infections over nonantimicrobial soap," while laboratory evidence consistently showed triclosan-resistant bacteria developing cross-resistance to clinical antibiotics like amoxicillin (Giuliano & Rybak, 2015).
The Bacteria Fight Back
Here the risk calculus inverts. Antibacterial soap doesn't just fail to help. It may cause harm. When bacteria encounter sub-lethal concentrations of triclosan, some develop mutations in the fabI gene that confer cross-resistance to clinically important antibiotics, and several laboratory studies in Aiello's review documented triclosan-adapted E. coli showing exactly this pattern at the concentrations found in consumer soap. Population-level antibiotic resistance directly attributable to consumer triclosan hasn't been definitively measured yet, but the mechanism is clear and the direction is one-way.
By 2014, the CDC's National Health and Nutrition Examination Survey found triclosan in the urine of approximately 75% of Americans tested. Three-quarters of the population, exposed to a chemical with zero demonstrated benefit and a documented mechanism for breeding resistant bacteria.
An Original Calculation
The U.S. antibacterial soap market was estimated at roughly $1 billion annually before the ban. Products were priced 20–40% above plain soap equivalents. If none of that premium buys additional germ protection, American consumers were collectively spending $200–400 million per year on a chemical requiring nine hours of skin contact to outperform the $1 bar next to it on the shelf. Per household: $40–100 annually. Return on that investment, per 27 studies: zero.
The FDA Acts, 44 Years Late
On September 6, 2016, the FDA ruled that 19 active ingredients in consumer antiseptic washes were not generally recognized as safe and effective, giving manufacturers one year to reformulate or pull their products from shelves. "We have no scientific evidence that they are any better than plain soap and water," said Dr. Janet Woodcock, the FDA's drug center director.
Congress first asked the FDA to evaluate triclosan in 1972, and forty-four years passed before the agency issued its final ruling only after the Natural Resources Defense Council sued.
The Strongest Case Against
Don Schaffner, a food microbiologist at Rutgers, argued that the negative findings are partly a formulation artifact. "Soap formulation is a tricky business," he told Chemistry World. "I remain convinced that properly formulated antimicrobial soaps have a benefit over bland, non-antimicrobial soaps."
That is a fair point, because the studies compared triclosan added to a soap base against the same base without it. A differently engineered product might perform better. But here is the problem: if the formulations actually sold to consumers for decades didn't work, the existence of a hypothetical better version is academic for the hundreds of millions already exposed to the real one.
What We Didn't Prove
This finding applies to consumer-concentration triclosan (0.1%–0.45%) during normal handwashing; higher concentrations used in hospital settings with longer contact times may yield genuine benefit, and the results should not be extrapolated to surgical scrub or healthcare antiseptics. No RCT has tested whether removing antibacterial soap from a household changes illness rates. The cross-resistance mechanism documented in laboratories has not been causally linked to population-level antibiotic resistance, though environmental persistence of triclosan in waterways remains an active concern.
The Bottom Line
Plain soap works because it dislodges bacteria and viruses mechanically, assisted by surfactants that dissolve lipid membranes, and twenty seconds of friction and rinsing is what actually does the work, while triclosan at consumer concentrations and normal contact times contributes nothing measurable to that process.
A dollar bar of plain soap, properly used, matches every antibacterial product ever sold to the American public. Two decades of evidence said so. The regulators finally agreed.
What You Can Do
Check your labels. Most manufacturers reformulated after the 2016 ban, but some products still carry "antibacterial" branding using permitted ingredients like benzalkonium chloride. Plain soap is equally effective and costs less.
Wash properly. The CDC recommends at least 20 seconds of lathering. Friction matters more than chemistry. Scrub between fingers, under nails, and the backs of hands.
Save the premium. Switching from antibacterial to plain soap saves a typical household $30–80 a year with no change in health outcomes.